Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 13,288 | 12,839 | 0 | 0 | 0 |
| Cost of Goods | 1,305 | 2,945 | N/A | N/A | N/A |
| Gross Profit | 11,983 | 9,894 | N/A | N/A | N/A |
| Operating Expenses | 17,897 | 31,176 | 55,903 | 33,366 | 37,482 |
| Operating Income | -5,609 | -20,337 | -55,903 | -33,366 | -37,482 |
| Interest Expense | 7,090 | 6,514 | 7,087 | 7,337 | 7,127 |
| Other Income | -95 | 2,307 | 6,398 | -2,726 | 28,078 |
| Pre-tax Income | -12,794 | -24,544 | -56,592 | -43,429 | -16,531 |
| Income Tax | -34 | -22 | -126 | -43 | -15 |
| Net Income Continuous | -12,760 | -24,522 | -56,466 | -43,386 | -16,516 |
| Net Income | $-12,760 | $-24,522 | $-56,466 | $-43,386 | $-16,516 |
| EPS Basic Total Ops | -3.21 | -13.23 | -50.40 | -47.36 | -18.08 |
| EPS Basic Continuous Ops | -3.21 | -13.23 | -50.39 | -47.37 | -18.10 |
| EPS Diluted Total Ops | -3.21 | -13.23 | -50.40 | -47.36 | -18.08 |
| EPS Diluted Continuous Ops | -3.21 | -13.23 | -50.39 | -47.37 | -18.10 |
| EPS Diluted Before Non-Recurring Items | -3.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,031 | $-18,377 | $-53,961 | $-31,469 | $-35,691 |